Absence of HBV Reactivation in Patients With Resolved HBV Infection Following DAA Therapy for Hepatitis C: A 1-Year Follow-up Study

BACKGROUND: Patients with chronic hepatitis C virus (HCV) infection and active or previous hepatitis B virus (HBV) are at risk of HBV reactivation (HBV-R) during direct-acting antiviral (DAA) therapy. Recent reports suggest that HBV-R may even occur several months after completion of DAA therapy. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mücke, Marcus M, Mücke, Victoria T, Peiffer, Kai-Henrik, Sarrazin, Christoph, Zeuzem, Stefan, Berger, Annemarie, Vermehren, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Editor's Choice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329904/
https://www.ncbi.nlm.nih.gov/pubmed/30648130
http://dx.doi.org/10.1093/ofid/ofy340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329904/
https://www.ncbi.nlm.nih.gov/pubmed/30648130
http://dx.doi.org/10.1093/ofid/ofy340

Ejemplares similares